text.skipToContent text.skipToNavigation
Need help? Please contact us
You searched for "natural killer cells"
Too many choices? Use the filter option on the left to narrow your product listing.
361-370 of 778 results
  • NHOst – Human Osteoblasts
    Compare
    NHOst – Human Osteoblasts
    Catalog #: CC-2538

    Cryopreserved ampule of Normal Human Osteoblasts (NHOst) containing ≥ 500,000 cells

    Sales unit: each
    EA
  • KGM™ Gold Keratinocyte Growth Medium BulletKit™
    Compare
    KGM™ Gold Keratinocyte Growth Medium BulletKit™
    Catalog #: 00192060
    Culture system containing KBM™ Gold™ Basal Medium (00192151) and KGM™ Gold™ SingleQuots™supplements (00192152) required for growth of human keratinocytes.
    Sales unit: kit
    SA
  • Irradiated Mouse Embryonic Fibroblasts (iMEF)
    Compare
    Irradiated Mouse Embryonic Fibroblasts (iMEF)
    Catalog #: M-IFB-482

    Cryopreserved ampule of Irradiated Mouse Embryonic Fibroblasts containing ≥2 million cells

    Sales unit: each
    EA
  • MEBM™ Mammary Epithelial Cell Growth Basal Medium, Phenol Red Free
    Compare
    MEBM™ Mammary Epithelial Cell Growth Basal Medium, Phenol Red Free
    Catalog #: CC-3153
    MEBM™ Mammary Epithelial Basal Medium, Phenol Red Free, for culture of human mammary epithelial cells, 500 mL.
    Sales unit: each
    EA
  • MycoZap™ Plus-PR
    Compare
    MycoZap™ Plus-PR
    Catalog #: VZA-2022

    Antibiotic formulation for prevention of bacteria, fungi and mycoplasma contaminations in primary cell cultures.

    Sales unit: items
    ST
  • MycoZap™ Plus-PR
    Compare
    MycoZap™ Plus-PR
    Catalog #: VZA-2021
    Antibiotic formulation for prevention of bacteria, fungi and mycoplasma contaminations in primary cell cultures.
    Sales unit: items
    ST
  • SABM™ Small Airway Epithelial Cell Growth Basal Medium
    Compare
    SABM™ Small Airway Epithelial Cell Growth Basal Medium
    Catalog #: CC-3119
    SABMTM Small Airway Epithelial Basal Medium
    Sales unit: each
    EA
  • ProCHO<sup class=reg>®</sup> 4 Protein-free CHO Medium, 1L
    Compare
    ProCHO® 4 Protein-free CHO Medium, 1L
    Catalog #: 04-919Q

    ProCHO® 4 Protein-free CHO Medium with 0.1% Pluronic® F-68, without L-Glutamin, phenol red, hypoxanthine or thymidine, 1 L.

    Sales unit: each
    EA
  • D-HBE-As – Diseased Human Bronchial/Tracheal Epithelial Cells – Asthma for B-ALI™ Culture
    Compare
    D-HBE-As – Diseased Human Bronchial/Tracheal Epithelial Cells – Asthma for B-ALI™ Culture
    Catalog #: 00194911S
    DHBE-As, Bronchial Epithelial Cells from donors having Asthma for B-ALI™ (Bronchial Air Liquid Interface) cell culture
    Sales unit: Ampule
    AMP
  • ProCHO<sup class=reg>®</sup> 5 Protein-free CHO Medium, 1L
    Compare
    ProCHO® 5 Protein-free CHO Medium, 1L
    Catalog #: BELN12-766Q

    ProCHO® 5 protein free CHO medium, with HEPES and 0.1% Pluronic® F-68, without L-Glutamine, phenol red, hypoxanthine or thymidine, 1 L (NAO)

    Sales unit: each
    EA
1-10 of 1102 results
  • Natural Killer Cells Infographic
    Natural Killer cells have an innate ability to recognize and destroy non-self cells.
  • 3D Natural Killer Cell-mediated Cytotoxicity Assay
    Lonza White Paper
  • 3D Natural Killer (NK) Cell-mediated Cytotoxicity (CMC) Assay
    Watch Video
  • Natural Killer (NK) Cell Expansion, Activation and Cytotoxicity Assay
    Protocol instructions
  • Therapeutic Approaches to Enhance Natural Killer Cell Cytotoxicity: The Force Awakens
    Poster published by Nature Reviews Drug Discovery, sponsored by Lonza. Natural killer (NK) cells are emerging as attractive candidates for new immunotherapeutic approaches. The poster shows the approaches to NK cell tumor targeting.
  • Transfection Protocol for Human NK Cells - Nucleofector™ I/II/2b Device Series
    Instructions of use for transfection of human natural killer cells with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
  • An Innovative, Highly Efficient Method for Transfecting Large Quantities of Primary Human T-cells
    A strong need exists for improved cancer treatment options. Lonza's approach relies on genetically modified, patient-derived cells like T-cells or natural killer cells which express chimeric antigen receptors (CAR) targeting cancer cells.
  • NK Cell Assay using 3D Bioprinted Tumor Models
    This white paper describes an ex vivo assay for NK cell killing activity in a 3D bioprinted cervical cancer tumor model.
  • TechSheet - Poietics™ Human Immune System Cells
    Technical Product Information Sheet
  • CAR T cells in Cancer Therapy
    A poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.